Nucleus RadioPharma Appoints Tyrell Rivers as Executive Director of Corporate Ventures
Company
Nucleus RadioPharma
DavidsonManufacturingBiotechnologyHealth CarepharmaceuticalsDescription
Nucleus RadioPharma has announced the closing of a Series A extension round with new investor AstraZeneca. Concurrent with the financing, Tyrell Rivers was appointed as the Executive Director of Corporate Ventures at AstraZeneca.
Quick answer
Nucleus RadioPharma Appoints Tyrell Rivers as Executive Director of Corporate Ventures (June 5, 2024). Nucleus RadioPharma is based in Davidson, North Carolina, United States.
- What did Nucleus RadioPharma announce on June 5, 2024?
- Nucleus RadioPharma has announced the closing of a Series A extension round with new investor AstraZeneca. Concurrent with the financing, Tyrell Rivers was appointed as the Executive Director of Corporate Ventures at AstraZeneca.
- What does Nucleus RadioPharma do?
- Nucleus RadioPharma is an innovative CDMO dedicated to the development and manufacturing of targeted radiotherapies.
- Where is Nucleus RadioPharma based?
- Nucleus RadioPharma is based in Davidson, North Carolina, United States.
- Which similar companies made leadership changes around the same time?
- Dr. Reddy's Laboratories (May 28, 2024), Allurion Technologies (June 5, 2024), Danaher (June 5, 2024) and Neurovalens (June 5, 2024) also announced leadership changes within 45 days of Nucleus RadioPharma.
Source: Fundz verified event record.
Other recent leadership changes in pharmaceuticals and Manufacturing
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Dr. Reddy's Laboratories Appoints Milan Kalawadia as Chief Executive Officer (North America) (May 28, 2024)
- Allurion Technologies, Inc. Appoints Ojas A. Buch as Chief Operating Officer (June 5, 2024)
- Danaher Corporation Appoints Dr. Martin Stumpe as Chief Data & Artificial Intelligence (AI) Officer (June 5, 2024)
- Neurovalens Appoints Kate Willis as Vice President of Commercialization (June 5, 2024)
- Eli Lilly and Company Appoints Melissa Seymour as Executive Vice President of Global Quality (June 4, 2024)
- Contineum Therapeutics Appoints John Healy as General Counsel & Corporate Secretary (June 3, 2024)
Who to call at Nucleus RadioPharma, and when
A new leader at Nucleus RadioPharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nucleus RadioPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nucleus RadioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleus RadioPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleus RadioPharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nucleus RadioPharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.